Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis

References

• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC; 2007.
   Google Scholar
• Mineo JF, Bordron A, Baronchi M, et al. Prognostic factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007;149:245–53.
   PubMed Web of Science ®Google Scholar
• Dixit S, Hingorani M, Achawal S, Scott IS. The sequential use of carmustine wafers (Gliadel) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review. Br J Neurosurg 2011;25:459–69.
   PubMed Web of Science ®Google Scholar
• Murray AW, Hunt T. The Cell Cycle. New York: Freeman; 1993.
   Google Scholar
• Nasmyth K. Viewpoint: Putting the cell cycle in order. Science 1996;274:1643–5.
   PubMed Web of Science ®Google Scholar
• Stillman B. Cell cycle control of DNA replication. Science 1996;274:1659–63.
   PubMed Web of Science ®Google Scholar
• Bell SP, Dutta A. DNA replication in eukaryotic cells. Ann Rev Biochem 2002;71:333–74.
   PubMed Web of Science ®Google Scholar
• Coverley D, Laskey RA. Regulation of eukaryotic DNA replication. Ann Rev Biochem 1994;63:745–76.
   PubMed Web of Science ®Google Scholar
• Bartek J, Lucas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001;13:738–47.
   PubMed Web of Science ®Google Scholar
• Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Ann Rev Genetics 2002;36:617–56.
   PubMed Web of Science ®Google Scholar
• Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075–9.
   PubMed Web of Science ®Google Scholar
• Scott IS, Morris LS, Rushbrook SM, et al. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology. Neuropathol Appl Neurobiol 2005;31:455–66.
   PubMed Web of Science ®Google Scholar
• Hama S, Matsuura S, Tauchi H, et al. p16 gene transfer increases cell killing with abnormal nucleation after ionising radiation in glioma cells. Br J Cancer 2003;89:1802–11.
   PubMed Web of Science ®Google Scholar
• Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophys J 1963;3:11–33.
   PubMed Web of Science ®Google Scholar
• Lei M, Tye BK. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 2001;114:1447–1454.
   PubMed Web of Science ®Google Scholar
• Madine M, Laskey RA. Geminin bans replication licence. Nat Cell Biol 2001;3:E49–50.
   Web of Science ®Google Scholar
• Kearsey SE, Labib K. MCM proteins: evolution, properties and role in DNA replication. Biochem Biophys Acta 1998;1398:113–36.
   PubMed Web of Science ®Google Scholar
• Maiorano D, Van Assendelft GB, Kearsey SE. Fission yeast cdc21, a member of the MCM protein family, is required for onset of S-phase and is located in the nucleus throughout the cell cycle. EMBO J 1996;15:861–72.
   PubMed Web of Science ®Google Scholar
• Musahl C, Holthoff HP, Lesch R, Knippers R. Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp Cell Res 1998;241:260–4.
   PubMed Web of Science ®Google Scholar
• Todorov IT, Werness BA, Wang HQ, et al. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 1998;78:73–8.
   PubMed Web of Science ®Google Scholar
• Laskey RA, Madine MA. A rotary pumping model for helicase function of MCM proteins at a distance from replication forks. EMBO Rep 2003;4:26–30.
   PubMed Web of Science ®Google Scholar
• Pines J, Hunter T. Cyclins A and B1 in the human cell cycle. Ciba Found Symp 1992;170:187–96.
   PubMedGoogle Scholar
• Xouri G, Dimaki M, Bastiaens PIH, Lygerou Z. Cdt1 interactions in the licencing process: a model for dynamic spatiotemporal control of licensing. Cell Cycle 2007;6:1549–52.
   PubMed Web of Science ®Google Scholar
• Wohlschlegel JA, Dwyer BT, Dhar SK, et al. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 2000;290:2309–12.
   PubMed Web of Science ®Google Scholar
• Wohlschlegel JA, Kutok JL, Weng AP, Dutta A. Expression of geminin as a marker of cell proliferation in normal tissues and malignancies. Am J Pathol 2002;161:267–73.
   PubMed Web of Science ®Google Scholar
• Nishitani H, Taraviras S, Lygerou Z, Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilised after initiation of S-phase. J Biol Chem 2001;276:44905–11.
   PubMed Web of Science ®Google Scholar
• Wharton SB, Hibberd S, Eward KL, et al. DNA replication licencing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer 2004;91:262–9.
   PubMed Web of Science ®Google Scholar
• Hara A, Saegusa M, Ichinoe M, Okayasu I. Diagnostic and prognostic significance of cyclin A expression in low grade astrocytomas: comparison with astrogliosis and high grade tumours. J Clin Pathol 2008;61:287–92.
   PubMed Web of Science ®Google Scholar
• Shresta P, Saito T, Hama S, et al. Geminin: a good prognostic factor in high grade astrocytic brain tumours. Cancer 2007; 109:949–56.
   PubMed Web of Science ®Google Scholar
• Sallinen PK, Haapasalo HK, Visakorpi T, et al. Prognostication of astrocytoma patient survival by Ki67 (Mib-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994;174:275–82.
   PubMed Web of Science ®Google Scholar
• Wharton SB, Chan KK, Anderson JR, Stoeber K, Williams GH. Replicative Mcm-2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol 2001;27:305–13.
   PubMed Web of Science ®Google Scholar
• Tamura T, Shomori K, Haruki T, et al. Minichromosomal maintenance protein-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study. J Oral Pathol Med 2010;39:328–34.
   PubMed Web of Science ®Google Scholar
• Nishihara K, Shomori K, Tamura T, et al. Immunohistochemical expression of geminin in colorectal cancer: implication of prognostic significance. Oncol Rep 2009;21:1189–95.
   PubMed Web of Science ®Google Scholar
• Gonzalez MA, Tachibana KK, Chin SF, et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 2004;204:121–30.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Oyaizu H, Dutta A, Inoue I. The destruction box of human geminin is critical for proliferation and tumour growth in human colon cancer cells. Oncogene 2004;23:58–70.
   PubMed Web of Science ®Google Scholar